Femasys (FEMY) Common Equity (2020 - 2026)
Femasys' Common Equity came in at $4.03 million for Q2 2026, up 167.4% from $1.51 million a year earlier but down 44.7% from the prior quarter.
Analysis
Femasys (FEMY) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Femasys' Common Equity was $5.87 million, up 154.7% from FY2024.
- Going back by year, Common Equity was $2.3 million in FY2024 (-87.4%), $18.35 million in FY2023 (+20.4%), $15.24 million in FY2022 (-42.1%) and $26.33 million in FY2021.
- The five-year range for quarterly Common Equity is $1.51 million (Q2 2025) to $28.65 million (Q3 2021).
- Year-over-year, Common Equity has increased for three consecutive quarters, with growth averaging 32.4% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in Q1 2026 (growth of 265.1%), and the weakest in Q4 2024 (a decline of 87.4%).
- Business Quant data shows FEMY's Common Equity at $7.29 million (Q1 2026), $5.87 million (Q4 2025) and $4.56 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 52.69 Bn |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 51.76 Bn |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 52.59 Bn |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 18.30 Bn |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 23.99 Bn |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 25.17 Bn |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 10.72 Bn |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 24.42 Bn |
| 10 | Femasys | 6.32 Mn | -14.34 Mn | 189,391.00 | 4.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.03 Mn |
| Mar 31, 2026 | 7.29 Mn |
| Dec 31, 2025 | 5.87 Mn |
| Sep 30, 2025 | 4.56 Mn |
| Jun 30, 2025 | 1.51 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 5.97 Mn |
| Jun 30, 2024 | 11.25 Mn |
| Mar 31, 2024 | 15.61 Mn |
| Dec 31, 2023 | 18.35 Mn |
| Sep 30, 2023 | 10.44 Mn |
| Jun 30, 2023 | 12.88 Mn |
| Mar 31, 2023 | 12.36 Mn |
| Dec 31, 2022 | 15.24 Mn |
| Sep 30, 2022 | 18.01 Mn |
| Jun 30, 2022 | 20.94 Mn |
| Mar 31, 2022 | 23.49 Mn |
| Dec 31, 2021 | 26.33 Mn |
| Sep 30, 2021 | 28.65 Mn |
API Access
Femasys Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=FEMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "FEMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=FEMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();